Pembrolizumab and nivolumab show favorable response rates with or without consolidation therapy.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/icis-show-favorable-responses-mediastinal-b-cell-lymphoma-2026a1000d32?src=rss
Author :
Publish date : 2026-04-24 12:51:00
Copyright for syndicated content belongs to the linked Source.